Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib - Response Journal Article

  

Authors:	Rini, B. I.; Cohen, D. P.; Lu, D. R.; Chen, I.; Hariharan, S.; Gore, M. E.; Figlin, R. A.; Baum, M. S.; Motzer, R. J.
Article Title:	Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib - Response
Keywords:	vasculotropin; single nucleotide polymorphism; bevacizumab; sunitinib; hypertension; drug targeting; outcome assessment; letter; gene expression; kidney carcinoma; diastolic blood pressure; systolic blood pressure; axitinib; blood pressure monitoring
Journal Title:	JNCI: Journal of the National Cancer Institute
Volume:	103
Issue:	20
ISSN:	0027-8874
Publisher:	Oxford University Press
Date Published:	2011-10-19
Start Page:	1558
Language:	English
DOI:	10.1093/jnci/djr329
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-80054963802&partnerID=40&md5=51c3e2938331e5e08b3a2e6fca0e2b65
Notes:	--- - "Export Date: 9 December 2011" - "CODEN: JNCIA" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/15866